baber/WOPTO huggingface dataset:
Patent CA-2839761-A1 (CA)
Inventor: CHOUDHRY OMAR HUSSAIN
IPC: G06F3/14
Filed: 2014-01-20
Abstract: Described are various embodiments of a content digitization and digitized content characterization system and method. For example, digitized content items may have content elements of interest extracted therefrom for remote characterization by a set of system users while mitigating, if not eliminating, concerns as to content privacy, confidentiality and/or securing.
Patent CA-2841342-A1 (CA)
Inventor: DING YAO
IPC: G06F3/033
Filed: 2012-07-09
Abstract: A stylus that includes a tip portion that has a cavity. The cavity has a plurality of holes at a first end and a transmitter of acoustic, e.g., ultrasound waves at the end longitudinally opposite the first end. The tip portion has a tip. The tip end is less than a quarter of a wavelength from the exit ends of the holes. When the end of the tip is placed against a working surface, the acoustic waves travel from the transmitter through the cavity, exit the holes and travel less than a quarter of a wavelength to the working surface relatively close to the tip.
Patent CA-2843133-A1 (CA)
Title: Systems and methods for controlling operation of a reduced pressure therapy system
Inventor: ALLEN JULIE
IPC: A61M1/00
Filed: 2011-11-02
Abstract: Negative pressure wound therapy apparatuses and dressings, and systems and methods for operating such apparatuses for use with dressings are disclosed. In some embodiments, controlling the delivery of therapy can be based on monitoring and detecting various operating conditions. An apparatus can have a controller configured to monitor the duty cycle of a source of negative pressure and, based on the monitored duty cycle, determine whether a leak is present. The controller can be configured to provide an indication that a leak is present. For example, the controller can be configured to suspend and/or pause the delivery of therapy, and to restart the delivery of therapy due to a timeout, request from a user, etc. In addition, the controller can be configured to pause and/or restart the delivery of therapy upon a request from the user, such as in response to the user operating a switch.
Patent CA-2843648-A1 (CA)
Title: Chemical identification using a chromatography retention index
Inventor: SADOWSKI CHARLES
IPC: G01N30/72
Filed: 2012-08-03
Abstract: Provided herein is technology relating to identifying unknown compounds and particularly, but not exclusively, to methods and systems for identifying unknown compounds by gas chromatography-mass spectrometry by use of retention index as a second dimension for identification.
Patent CA-2844011-A1 (CA)
Title: Drain seal
Inventor: LIPTAK ANDREW J
IPC: E04D13/04
Filed: 2014-02-25
Abstract: A sealing assembly for fluidly sealing a roof drain within a conductor pipe has a sealing element and an expansion ring. The sealing element defines an inner wall with a portion that transitions inward and may be disposed on a portion of the roof drain. The expansion ring is disposed within the inner wall. Reciprocation of the of the expansion ring along the inward transitioning portion of the inner wall causes the sealing element to expand outwardly to a sealed position with the sealing element outer wall abutting the conductor pipe inner wall in a fluid tight seal. Opposite reciprocation of the ring allows the sealing element to contract and release from the conductor pipe.
Patent CA-2844907-A1 (CA)
Inventor: BAKHRU SASHA H
IPC: A61P25/00
Filed: 2012-08-09
Abstract: Formulations of a neuroprotective agent for parenteral administration are described herein. The formulation is in the form of a concentrated (supersaturated) solution or a concentrated suspension of microparticles. The suspension medium or the solution solvent carrier may also contain dissolved neuroprotective agent. For the supersaturated solutions, the agent is dissolved at high concentrations of at least about 1% by weight, 5% by weight, 10% by weight, 15% by weight, or 20% by weight in a solvent suitable for parenteral administration. For the concentrated suspension, the microparticles have an effective particle size from about 100 nm to about 5 microns, preferably from about 50 nm to about 3 microns, more preferably from about 10 nm to about 2 microns. The formulations described herein can be used to treat a variety of neurological diseases/disorders and/or neurological injury or trauma.
Patent CA-2845080-A1 (CA)
Title: Actionneur de soupape electro-hydraulique a came alternative
Inventor: RABHI VIANNEY
IPC: F01L9/10
Filed: 2012-10-11
Abstract: L'actionneur de soupape électro-hydraulique à vérin et came alternative suivant la présente invention comprend : un vérin hydraulique actionneur de soupape (2) qui ouvre une soupape d'un moteur à combustion interne (100) au moyen d'une électrovanne d'ouverture de soupape (4), d'un conduit haute pression d'ouverture de soupape (11) et d'un circuit hydraulique haute pression entrant (5), et qui ferme ladite soupape au moyen d'une électrovanne de fermeture de soupape (6),d'un conduit haute pression de fermeture de soupape (12) et d'un circuit haute pression sortant (7), une pompe hydraulique volumétrique (8) coopérant avec un clapet anti retour d'entrée de pompe (14) et une électrovanne d'obturation de sortie de pompe (13) et dont la sortie est reliée à un circuit basse pression (9) et à un réservoir basse pression (10) alimenté par une pompe de réapprovisionnement (52) et un réservoir de réapprovisionnement (53).
Patent CA-2845884-A1 (CA)
Inventor: CASSAN ROBYN
IPC: A61K39/40
Filed: 2012-08-22
Abstract: Compositions and methods for the treatment or prevention of Clostridium difficile infection in a subject are provided. The compositions comprise antibodies to Clostridium difficile toxin A. The methods provide for administering the antibodies to a subject in an amount effective to reduce or eliminate or prevent relapse from Clostridium difficile bacterial infection.
Patent CA-2846539-A1 (CA)
Title: Solar panels with contactless panel-to-panel connections
Inventor: RODRIGUES TOMMY F
IPC: H02J17/00
Filed: 2014-03-14
Abstract: A solar panel array comprises a first plurality of solar panels arranged side-by-side in a first course and a second plurality of solar panels arranged side-by-side in a second course, the second course partially overlapping the first course. Electrical energy produced by each solar panel of the array is aggregated with the electrical energy produced by the other solar panels of the array without physical electrical contacts between the solar panels. In one embodiment, contactless inductive couplers are used to couple the electrical energies of the panels together.
Patent CA-2847211-A1 (CA)
Inventor: HERDEN MARC-OLIVER
IPC: B60T8/17
Filed: 2012-09-07
Abstract: The invention relates to a control device (28) for a rail vehicle (10), said rail vehicle (10) comprising a braking system with at least one dynamic braking device (17) and at least one further braking device (23, 24, 26). The control device (28) is designed to determine the brake force exerted by the dynamic braking device (17) during braking based on deceleration data, which represent an overall deceleration of the rail vehicle, tractive resistance data, which represent a tractive resistance of the rail vehicle, and braking data, which represent a brake force exerted by the at least one further braking device. The invention further relates to a braking system comprising said control device (28), a rail vehicle (10) and a corresponding method.
Patent CA-2847677-A1 (CA)
Inventor: SCHWAEBLE HANS-WILHELM
IPC: A61P21/00
Filed: 2005-06-09
Abstract: Dans un aspect, linvention fournit des méthodes dinhibition des effets associés à lactivation du complément dépendant de MASP-2 chez un sujet vivant. La méthode comprend les étapes dadministration, à un sujet en ayant besoin, dune quantité dagent inhibiteur de MASP-2 efficace pour inhiber lactivation du complément dépendant de MASP-2. Dans certains modes de réalisation, lagent inhibiteur de MASP-2 inhibe la blessure cellulaire associée à lactivation du parcours du complément alternatif médié par MASP-2, tout en laissant intacte la composante de parcours classique (dépendant de C 1 q) du système immunitaire.  Dans un autre aspect, linvention fournit des compositions servant à linhibition des effets de lactivation du complément dépendant de la lectine, comprenant une quantité thérapeutiquement efficace dagent inhibiteur de MASP-2 et un support pharmaceutiquement acceptable.
Patent CA-2850272-A1 (CA)
Title: Method for producing a structure and product produced by the method
Inventor: HANSEN BERND
IPC: B23K26/00
Filed: 2012-09-26
Abstract: A method for producing at least one structure (13) by way of laser action on at least one wall part (11) of a container wall (29) of a product, preferably a plastics container product (1) produced by a blow-moulding, filling and sealing method, is characterized in that the particular structure (13) is introduced by means of the laser action, at least with the laser power, the period of action of the laser, the type of plastics material and the type of desired structure being taken into account, as a linear depression (17) in the one wall part (11), such that said depression (17) is delimited at the edge and in a manner following the profile of the linear depression (17) by in each case one elevation (27) which is brought about under the influence of the intrinsic material stress of the plastics material.
Patent CA-2850469-A1 (CA)
Inventor: SAKAMOTO IZUMI
IPC: A61P43/00
Filed: 2012-09-28
Abstract: [Problem] To provide a glycosylated polypeptide having a uniform carbohydrate structure, wherein the glycosylated polypeptide has interferon ß activity. [Solution] It was discovered that a glycosylated polypeptide having a uniform carbohydrate structure and having interferon ß activity can be produced by a method that includes a step for synthesizing a glycosylated peptide fragment and at least two peptide fragments and a step for linking the glycosylated peptide fragment and the at least two peptide fragments.
Patent CA-2853061-A1 (CA)
Inventor: LOOPER ANTHONY M
IPC: A61M25/00
Filed: 2012-10-11
Abstract: System and components for inducing pleurodesis while minimizing likelihood of tissue damage from direct application of pleurodesisenhancing materials. A tube device is provided that is configured to elute pleurodesis-enhancing material. The device includes one or more features configured to prevent or lessen the likelihood that the pleurodesisenhancing material comes into direct and concentrated contact with patient tissue when a distal length of the device is disposed indwelling a patient.
Patent CA-2854220-A1 (CA)
Title: Sequentialized key duplication system
Inventor: BURKETT MICHAEL WILSON
IPC: B23C3/35
Filed: 2014-06-12
Abstract: An integrated key duplication machine includes a machine-based key identification module and a key cutting module. The key identification module is configured to identify a second master key while the key cutting module cuts a key blank corresponding to a first master key. A key blank corresponding to the second master key can be cut on either the integrated machine or a stand-alone machine having only key cutting capabilities.
Patent CA-2854755-A1 (CA)
Title: Method and device for riserless drilling fluid recovery
Inventor: EIKEMO BERNT
IPC: E21B7/20
Filed: 2012-10-25
Abstract: A method and a device for enabling the use of riserless drilling fluid recovery from a seabed-based borehole (1) which is to be drilled by means of a casing (26), the casing (26) being provided with a drill bit (28) at its lower portion and with an inner wellhead (30) at its upper portion, and there being a conductor casing (6), which has an outer wellhead (8), in the seabed (2), the method including: - providing a suction module (12) with a dividable adapter (16) which fits complementarily in the outer wellhead (8); - drilling a length of the borehole (1) by means of the casing (26) extending through the suction module (12), while, at the same time, drilling fluid is flowing via the suction module (12) from the borehole (1); - subsequently pulling the adapter (16) up from the outer wellhead (8) and dividing the adapter (16); and - lowering the casing (26) with the inner wellhead (30) through the suction module (12) and the adapter (16) to its position in the outer wellhead (8).
Patent CA-2855934-A1 (CA)
Title: Freely-foldable flexible led screen
Inventor: LIU YANPING
IPC: G09F9/33
Filed: 2013-12-05
Abstract: A freely-foldable flexible LED screen includes multiple LED sub-screens, PCBs disposed inside casings of the LED sub-screens, LEDs disposed on the PCB, and conducting wires electrically connecting the PCBs. Adjacent LED sub-screens are connected using a connection mechanism capable of freely rotating, which includes a rotation rod, and rotation shafts disposed at two ends of the rotation rod; the casing of the LED sub-screen includes a front casing and a rear casing; where grooves are symmetrically disposed at edges of the front and rear casings, the rotation shafts at two ends of the rotation rod are respectively installed in grooves in the casings of two adjacent LED sub-screens, the grooves of the front and rear casings are further provided with close covers connecting the rotation shafts, where the close cover corresponding to the rotation shaft is provided with a rotation shaft groove that is rotatably connected to the rotation shaft.
Patent CA-2859375-A1 (CA)
Title: Plug and abandonment system
Inventor: ABRAHAMSEN TERJE
IPC: E21B33/12
Filed: 2012-12-14
Abstract: A system to set a plug in a wellbore includes a tubular member and a plug coupled to the tubular member. The plug is configured to seal a wellbore based, at least in part, on a shape change of the plug.
Patent CA-2860144-A1 (CA)
Title: Method of exosome analysis, reagent for exosome analysis, and analyzer for exosome
Inventor: OCHIYA TAKAHIRO
IPC: G01N33/53
Filed: 2012-10-25
Abstract: Provided is an exosome analysis method which can analyze an exosome in a sample in a simple manner. The exosome analysis method according to the present invention is a method for analyzing an exosome in a sample, and is characterized by comprising: an addition step of adding a first antibody capable of binding specifically to a first antigen contained in the exosome and a second antibody capable of binding specifically to a second antigen contained in the exosome to the sample; a reaction step of reacting the first antigen with the first antibody and reacting the second antigen with the second antibody; and a detection step of detecting the reaction of the first antigen with the first antibody and the reaction of the second antigen with the second antibody.
Patent CA-2863744-A1 (CA)
Title: Locking mechanism for containers for transporting radioactive substances
Inventor: HILBERT FRANZ
IPC: G21F5/015
Filed: 2013-02-15
Abstract: A locking mechanism comprises a first component having a first comb-like section and a second component having a second comb-like section. There is a bolt element comprising a head portion and a shaft portion extending the head portion. There is a recess in the head portion. The recess extends perpendicularly to a longitudinal axis of the bolt element. The shaft portion is configured to pass through the first comb-like section and second comb-like section when the locking mechanism is in a locked position. The first component comprises an opening that is aligned with the recess in the head portion when the shaft portion is disposed within the first comb-like section and second comb-like section. A locking element is configured to be disposed in the opening. A  portion of the locking element extends into the recess in the head portion when the locking mechanism is in the locked position.
Patent CA-2865086-A1 (CA)
Title: Method of making border wire and apparatus for practicing method
Inventor: BROTTLUND VON W
IPC: A47C23/05
Filed: 2013-03-28
Abstract: An apparatus (10) is provided which makes a border wire (30) having a rectangular cross section. The apparatus (10) is adapted to receive a roll (14) of wire having a circular cross section, straighten the wire and change the cross-section of the wire to rectangular. The reconfigured wire (19) is then accumulated, passed through another straightener, cut to size and then bent into a rectangular configuration. Opposed ends of the piece of wire (36) having a rectangular cross section are welded together to complete the border wire (30). The apparatus has an ejector which removes the completed border wire (30) from the apparatus (10).
Patent CA-2865812-A1 (CA)
Inventor: GILLOT JULIEN
IPC: B42D15/00
Filed: 2013-03-05
Abstract: La présente invention se rapporte notamment à un document de sécurité, tel qu'un billet de banque, qui est formé d'une feuille (1) qui comporte au moins sur l'une de ses faces opposées (10, 11), au moins un repère saillant tactile ou «marque d'aveugle» (2) apte à permettre à des personnes non-ou malvoyantes, par le toucher dudit repère (2), d'identifier une caractéristique spécifique dudit document, telle que sa valeur faciale et de participer à la détermination de son authenticité, caractérisé par le fait que ledit repère (2) est au moins partiellement entouré par au moins une première zone texturée (3), c'est-à-dire une surface dont le toucher est différent et se singularise de celui du reste de ladite feuille (1), sa seconde face (11, 10) présentant également une seconde zone texturée (4).
Patent CA-2866572-A1 (CA)
Inventor: DASS PRADEEP
IPC: F04B23/02
Filed: 2013-03-18
Abstract: A method of reducing leakage from a pipeline includes the steps of: pumping fluid through a pipeline using at least one pump, the at least one pump comprising a reversible, positive displacement fluid pump; detecting a leak in the pipeline downstream of the pump; reversing the at least one pump to draw fluid out of a downstream section of the pipeline; and redirecting the fluid being drawn from the pipeline into a storage container.
Patent CA-2867508-A1 (CA)
Inventor: SEPPO ANTTI E
IPC: G01N33/574
Filed: 2013-03-21
Abstract: L'invention concerne un procédé pour fournir une image composite d'un échantillon biologique unique, comprenant les étapes de génération d'une première image de l'échantillon biologique, de génération d'une seconde image de l'échantillon biologique et de génération d'une image composite qui fournit l'emplacement relatif à la fois de la protéine cible et de l'acide nucléique cible. L'invention concerne également un procédé d'analyse d'un échantillon biologique, comprenant l'apport d'une image composite de l'échantillon biologique selon le procédé pour fournir une image composite, et l'analyse de l'expression de la protéine et des séquences d'acide nucléique d'intérêt à partir de l'image composite. L'invention concerne en outre un système et une trousse qui comprennent les moyens de mise en uvre des nouveaux procédés.
Patent CA-2871324-A1 (CA)
Title: Substituted acyloxyamidines as hcv ns3/4a inhibitors
Inventor: LAMARRE DANIEL
IPC: C07D317/68
Filed: 2014-11-13
Abstract: Disclsoed herein is a compound of Formula l <See formula I) or a pharmaceutically acceptable salt thereof, in which A, G, R1 and R2 are as defined herein. The compounds and pharmaceutical compositions of the compounds are suitbale for the treatment of HCV infection in mammals and are also useful to modulate or inhibit NS3/4 dimerization.
Patent CA-2871864-A1 (CA)
Inventor: WALLING JOHN
IPC: A61K31/575
Filed: 2008-08-14
Abstract: A triterpenoid compound, methyl 2-cyano-3,12-dioxoleana- 1,9(11)-dien-28-oate (CDDO methyl ester), has a non-crystalline, glassy solid form and a non-hydrous crystalline form that can prepared, for example, from a saturated methanol solution. The glassy form displays an enhanced bioavailability over the non-hydrous crystalline form. Each form of CDDO methyl ester is a superior candidate for use, typically in solid dosage form, for treating a variety of disease states, generally associated with inflammation.
Patent CA-2872045-A1 (CA)
Inventor: STOJDL DAVID F
IPC: A61K35/766
Filed: 2012-06-07
Abstract: The present disclosure concerns an oncolytic virus for the treatment of cancer, such as in brain cancer, for example glioblastoma. The oncolytic virus may exhibit reduced levels of neurotoxicity. The oncolytic virus may be an isolated viral particle capable of producing a cDNA polynucleotide that includes a sequence according to SEQ ID NO: 1 when the virus is in a host cell. The oncolytic virus may be an isolated viral particle that includes an RNA polynuclotide that includes a sequence according to SEQ ID NO: 2. The oncolytic virus may be an isolated viral particle having a genome that includes open reading frames that encode: proteins having sequences comprising SEQ ID NOs: 3, 4, 5, 6 and 7; or variants thereof.
Patent CA-2872771-A1 (CA)
Title: Systems and methods of inhibiting foam formation using multiphase turbines
Inventor: SHEU FENG-RAN
IPC: C10L3/10
Filed: 2013-05-08
Abstract: Systems and methods for inhibiting foam formation in an acid gas removal system are provided. Preconditioning a rich amine or triethylene glycol stream exiting an absorber (102) of an acid gas removal system (100) through a rotary separation turbine (120) can provide pre-separation of gas (13) from rich amine or triethylene glycol (122), as well as effectively reduces or inhibits foam formation. Systems provided enhance plant reliability and also recovers hydraulic power into electricity.
Patent CA-2875821-A1 (CA)
Title: Flow structures for use with an electrochemical cell
Inventor: BLANCHET SCOTT
IPC: H01M4/80
Filed: 2013-06-12
Abstract: The design and method of fabrication of a three-dimensional, porous flow structure for use in a high differential pressure electrochemicai eel! is described. The flow structure is formed by compacting a highly porous metallic substrate and laminating at least one micro-porous material layer onto the compacted substrate. The flow structure provides void volume greater than about 55% and yield strength greater than about 12,000 psi. In one embodiment, the flow structure comprises a porosity gradient towards the electrolyte membrane, which helps in redistributing mechanical load from the electrolyte membrane throughout the structural elements of the open, porous flow structure, while simultaneously maintaining sufficient fluid permeability and electrical conductivity through the flow structure.
Patent CA-2876090-A1 (CA)
Inventor: DEVILLE JAY P
IPC: A01P1/00
Filed: 2013-05-24
Abstract: A method of converting an inactive biocide into an active biocide comprises: contacting the inactive biocide with an activating agent, wherein the activating agent is capable of chemically reacting with the inactive biocide; and causing or allowing a chemical reaction to take place between the inactive biocide and the activating agent, wherein the chemical reaction produces the active biocide. The methods can also include deactivating the active biocide via a chemical reaction between the active biocide and a deactivating agent.
Patent CA-2876110-A1 (CA)
Inventor: AOKI HIROFUMI
IPC: H04N21/236
Filed: 2013-05-31
Abstract: A video encoder (101) performs prediction-based encoding of image data in an input motion video, generating a video bitstream of encoded pictures. A refresh controller (102) designates partial areas of pictures as a refresh unit areas, and refreshes the pictures by shifting the refresh unit area in each of the pictures. A display-enabled area encoder (103) encodes display-enabled areas in each of the pictures in the refresh process, generating a display-enabled area information bitstream. A multiplexer (104) multiplexes the video bitstream and the display-enabled area information bitstream.